Eli Lilly laying off nearly 200 employees as it refocuses research efforts


File image

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

INDIANAPOLIS, Ind. – Nearly 200 Eli Lilly employees will lose their jobs as the Indianapolis-based company reduces its research and development workforce.

Eli Lilly says the cuts will help the company refocus efforts on certain key research areas like molecule-making capabilities, Alzheimer’s disease and immunology.

On Friday, many employees were offered what the company is calling a “voluntary exit program.” Those workers have until later this month to decide.

The reductions, which represent less than 3 percent of Lilly’s global R&D workforce, are not related to the recent failure of the company’s Alzheimer’s drug Solanezumab.

It’s not clear if the job cuts will come solely from Indianapolis.

Most Popular

Latest News

More News